BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36982185)

  • 1. Do We Preserve Tumor Control Probability (TCP) in FLASH Radiotherapy? A Model-Based Analysis.
    Liew H; Mein S; Tessonnier T; Abdollahi A; Debus J; Dokic I; Mairani A
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The minimal FLASH sparing effect needed to compensate the increase of radiobiological damage due to hypofractionation for late-reacting tissues.
    Böhlen TT; Germond JF; Bourhis J; Bailat C; Bochud F; Moeckli R
    Med Phys; 2022 Dec; 49(12):7672-7682. PubMed ID: 35933554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering Time-Dependent DNA Damage Complexity, Repair, and Oxygen Tension: A Mechanistic Model for FLASH-Dose-Rate Radiation Therapy.
    Liew H; Mein S; Dokic I; Haberer T; Debus J; Abdollahi A; Mairani A
    Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):574-586. PubMed ID: 33412259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viability of the EUD and TCP concepts as reliable dose indicators.
    Ebert MA
    Phys Med Biol; 2000 Feb; 45(2):441-57. PubMed ID: 10701514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FLASH radiotherapy treatment planning and models for electron beams.
    Rahman M; Trigilio A; Franciosini G; Moeckli R; Zhang R; Böhlen TT
    Radiother Oncol; 2022 Oct; 175():210-221. PubMed ID: 35964763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of local control due to tumor displacement as a function of margin size, dose-response slope, and number of fractions.
    Selvaraj J; Uzan J; Baker C; Nahum A
    Med Phys; 2013 Apr; 40(4):041715. PubMed ID: 23556885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simulation study of ionizing radiation acoustic imaging (iRAI) as a real-time dosimetric technique for ultra-high dose rate radiotherapy (UHDR-RT).
    Ba Sunbul NH; Zhang W; Oraiqat I; Litzenberg DW; Lam KL; Cuneo K; Moran JM; Carson PL; Wang X; Clarke SD; Matuszak MM; Pozzi SA; El Naqa I
    Med Phys; 2021 Oct; 48(10):6137-6151. PubMed ID: 34431520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour control probability: a formulation applicable to any temporal protocol of dose delivery.
    Zaider M; Minerbo GN
    Phys Med Biol; 2000 Feb; 45(2):279-93. PubMed ID: 10701504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Sub-Millisecond Damage Fixation Kinetics on the In Vitro Sparing Effect at Ultra-High Dose Rate in UNIVERSE.
    Liew H; Mein S; Tessonnier T; Abdollahi A; Debus J; Dokic I; Mairani A
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Voxel based evaluation of sequential radiotherapy treatment plans with different dose fractionation schemes.
    Singh G; Kamal R; Thaper D; Oinam AS; Handa B; Kumar V; Kumar N
    Br J Radiol; 2020 Aug; 93(1112):20200197. PubMed ID: 32614607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical data.
    Levegrün S; Jackson A; Zelefsky MJ; Skwarchuk MW; Venkatraman ES; Schlegel W; Fuks Z; Leibel SA; Ling CC
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):1064-80. PubMed ID: 11704332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
    Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
    J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of clinical outcome, radiobiological modeling of tumor control, normal tissue complication probability in lung cancer patients treated with SBRT using Monte Carlo calculation algorithm.
    Sood SS; Pokhrel D; Badkul R; TenNapel M; McClinton C; Kimler B; Wang F
    J Appl Clin Med Phys; 2020 Oct; 21(10):56-62. PubMed ID: 32794632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the impact of spatial oxygen heterogeneity on radiolytic oxygen depletion during FLASH radiotherapy.
    Taylor E; Hill RP; Létourneau D
    Phys Med Biol; 2022 Jun; 67(11):. PubMed ID: 35576920
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of SBRT fractionation on TCP and NTCP estimations for prostate cancer.
    Sukhikh ES; Sukhikh LG; Taletsky AV; Vertinsky AV; Izhevsky PV; Sheino IN
    Phys Med; 2019 Jun; 62():41-46. PubMed ID: 31153397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling dose response in the presence of spatial variations in dose rate.
    Ebert MA; Zavgorodni SF
    Med Phys; 2000 Feb; 27(2):393-400. PubMed ID: 10718144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling clinical outcomes in radiotherapy: NTCP, TCP and the "TECs".
    Yorke E
    Med Phys; 2023 Jun; 50 Suppl 1():122-124. PubMed ID: 36751020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FLASH radiotherapy sparing effect on the circulating lymphocytes in pencil beam scanning proton therapy: impact of hypofractionation and dose rate.
    Galts A; Hammi A
    Phys Med Biol; 2024 Jan; 69(2):. PubMed ID: 38081067
    [No Abstract]   [Full Text] [Related]  

  • 19. A theoretical investigation of adequate range uncertainty margins in proton treatment planning to preserve tumor control probability.
    Taasti VT; Jeong J; Jackson A; Deasy JO
    Acta Oncol; 2019 Oct; 58(10):1446-1450. PubMed ID: 31241385
    [No Abstract]   [Full Text] [Related]  

  • 20. Exploring trade-offs in treatment planning for brain tumor cases with a probabilistic definition of the clinical target volume.
    Buti G; Shusharina N; Ajdari A; Sterpin E; Bortfeld T
    Med Phys; 2023 Jan; 50(1):410-423. PubMed ID: 36354283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.